Kamila Agayeva, MD
Obstetrics & Gynecology · Brooklyn, NYNPI 1457364804
Payments from drug & device makers
Across 63 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$253
- Astellas Pharma US Inc$220
- Pfizer$179
- Sumitomo Pharma America, Inc.$101
- Therapeuticsmd, Inc.$101
- Hologic Sales And Service, LLC$99
- plus $416 from 12 others
What the payments were for
- Food & beverage$1,26092%
- Education$1088%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $253 |
| Astellas Pharma US Inc | 6 | $220 |
| Pfizer | 10 | $179 |
| Sumitomo Pharma America, Inc. | 4 | $101 |
| Therapeuticsmd, Inc. | 5 | $101 |
| Hologic Sales And Service, LLC | 6 | $99 |
| Evofem Biosciences, Inc. | 4 | $81 |
| Shield Therapeutics Inc | 3 | $71 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Mayne Pharma Commercial LLC | 2 | $31 |
| Mylan Pharmaceuticals Inc. | 1 | $27 |
| Lupin Inc. | 2 | $25 |
| Duchesnay USA Incorporated | 1 | $25 |
| Millicent US Inc | 1 | $24 |
| Myovant Sciences Inc. | 1 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $21 |
| Mission Pharmacal Company | 1 | $16 |
| Avion Pharmaceuticals | 1 | $12 |
How this compares
$1,368 in reported general payments places this provider in the 75th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 35 | $2,494 |
| Terconazole | 25 | $857 |
| Clobetasol Propionate | 16 | $814 |
| Metronidazole | 25 | $711 |
| ValacyclovirValacyclovir Hcl | 25 | $224 |
| Junel FeNorethindrone-E.Estradiol-Iron | 12 | $55 |
| Fluconazole | 34 | $52 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Brooklyn
- Miriam CremerBrooklyn$196K
- Michael LewisBrooklyn$62K
- Kathleen MorrellBrooklyn$48K
- Ila DayanandaBrooklyn$43K
- Yi-Chun LeeBrooklyn$38K
- Mark DefazioBrooklyn$27K
- Marina FrimerBronx$8.5M
- Nicole NevadunskyBronx$2.5M
- Jin Hee KimNew York$1M
- Carolyn WesthoffNew York$935K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.